Johnson & Johnson sues Biden administration to stop Medicare from negotiating its own drug prices
Johnson & Johnson (NYSE:JNJ) is suing the US government in a bid to block a program that would give the government health insurance program Medicare the ability to negotiate for lower drug prices. J&J is the latest major drugmaker to sue the Biden administration, joining Merck and Bristol Myers Squibb. The lobbyist group Pharmaceutical Research and Manufacturers of America have…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Boomers holding on to homes
Jury convicts former San Francisco PUC head of bank fraud, bribery
Advisor News
- Social cultivation: How to talk with wealthy prospects
- How important is a written financial plan?
- Coalition wants to advise people impacted by policy changes in new administration
- Diagnosing miscommunication in retirement planning
- Election creates an opportunity for advisor/client dialogue
More Advisor NewsAnnuity News
Health/Employee Benefits News
- Beware of scams during open enrollment for insurance
- Vermonters may be eligible for better health coverage
- Munson Healthcare offers help for Affordable Care Act enrollment
- Doctor’s bills often come with sticker shock for patients – but health insurance could be reinvented to provide costs upfront
- AI usage outpacing regulation, NAIC panel told
More Health/Employee Benefits NewsLife Insurance News